On April 29, 2022, the Chinese Academy of Sciences, Peking University and Tsinghua University preclinical research showed that NMN supplementation can rescue NAD+ metabolism, immune response and cell death-related gene expression dysregulation caused by new coronavirus infection, inhibit cell death in mice, and significantly improve Pneumonia caused by viral infection. The research results were included in the authoritative journal "Cell Discovery".

The results of this study support a new crown treatment experiment targeting the NAD+ pathway. The NAD+ precursor represented by NMN has become one of the bright spots. Structurally, NMN is the closest to NAD+ and can be converted to NAD+ in just one step. NMN-related industries, as intermediates for new crown treatment drugs, have a huge market and may attract new opportunities.

We Sinoway could supply you high quality S-adenosyl-L-methionine with competitive price. And we also have a professional team specialized in custom developing & manufacturing API, pharmaceutical intermediates, cosmetic raw materials and healthcare&food supplement ingredients. Please feel free to contact us at xie@china-sinoway.com